FDA approves Progensa

FDA approved a PMA for Progensa PCA3 assay from Gen-Probe Inc. (NASDAQ:GPRO) as an aid to determine the need for a repeat biopsy in men suspected of having prostate cancer. Gen-Probe has exclusive dia...